| CAS: | 49671-76-3 | |||
| 分子式: | C17H18N2 | |||
| 分子量: | 250.33 | |||
| 熔点: | 257-258℃ | |||
| 英文名称: |
| |||
| 性质描述: | 粉末 | |||
| 用途: | 生物活性分子，抑制剂类 |
| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |||||||||||||||||||||||
| T792959 | MACKLIN | 2-(4-叔丁基苯基)苯并咪唑 | 10mM in DMSO | 201元/1ml; | 咨询 | ||||||||||||||||||||||
储存：-20°C | |||||||||||||||||||||||||||
| T824603 | MACKLIN | 2-(4-叔丁基苯基)苯并咪唑 | 98% | 104元/25mg; 308元/100mg; | 咨询 | ||||||||||||||||||||||
储存：2~8°C,密封 状态：白色固体 物化性质：粉末 | |||||||||||||||||||||||||||
| SML0802 | Sigma-Aldrich | ZLN005 | ≥95% (HPLC) | 877.11元/10 MG; 2845.11元/50 MG; | 咨询 | ||||||||||||||||||||||
产品说明 包装 10, 50 mg in glass bottle 生化/生理作用 ZLN005 is a transcriptional regulator of peroxisome proliferator-activated receptor-γ coactivator-1α (PGC-1α). ZLN005 increased PGC-1 and downstream gene transcription in skeletal muscle, while reducing hepatic PGC-1α and gluconeogenesis genes. ZLN005 increased fat oxidation and improved the glucose tolerance, pyruvate tolerance, insulin sensitivity, hyperglycemia and dyslipidemia of diabetic db/db mice. 基本信息
产品性质
安全信息
| |||||||||||||||||||||||||||
| 468361 | Fluorochem | ZLN005 | 95% | 4950元/100mg; 12496元/500mg; | 咨询 | ||||||||||||||||||||||
基本信息
| |||||||||||||||||||||||||||
m.cnreagent.com